Signal transduction correlates of Mu opioid agonist intrinsic efficacy: Receptor-stimulated [35S]GTPγS binding in mMOR-CHO cells and rat thalamus

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 2, 1998, Pages 496-505

  Selley, Dana E ^a   Liu, Qixu ^a   Childers, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BUPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; LEVALLORPHAN; METHADONE; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALBUPHINE; NALORPHINE; NALOXONE; PETHIDINE; SUFENTANIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CHO CELL; DRUG EFFICACY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SIGNAL TRANSDUCTION; THALAMUS;

EID: 0031808576     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Abood M, Noel M, Carter R and Harris L (1995) Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected δ- and μ-opioid receptors. Biochem Pharmacol 50:851-859.
2. Adams J, Paronis C and Holtzman S (1990) Assessment of relative intrinsic activity of mu-opiold analgesics in vivo by using β-funaltrexamine. J Pharmacol Exp Ther 255:1027-1032.
3. 2-agonists in locus coeruleus neurons. Brain Res 371:390-394.
4. B receptors to the same channels in hippocampus. Science 234:1261-1265.
5. Asano T. Pedersen SE, Scott CW and Ross EM (1984) Reconstitution of catecholamine-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to the stimulatory GTP-binding protein of adenylate cyclase. Biochemistry 23:5460-5467.
6. 1A receptors: Variations in intrinsic activity studied in transfected HeLa cells. Naunyn-Schmiedebergs Arch Pharmacol 345:257-263.
7. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
8. Breivogel CS, Selley DE and Childers SR (1997) Acute and chronic effects of opioids on delta and mu receptor activation of G-proteins in NG108-15 and SK-N-SH cell membranes. J Neurochem. 68:1462-1472.
9. Carter BD and Medzihradsky F (1993) Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol Pharmacol 43:465-473.
10. 32P]GTP labeling of multiple G protein a subunits. J Neurochem 64:2534-2543.
11. Chavkin C and Goldstein A (1984) Opioid receptor reserve in normal and morphinetolerant guinea pig ileum myenteric plexus. Proc Natl Acad Sci USA 81:7253-7257.
12. Chen Y, Mestek A, Liu J, Hurley JA and Yu L (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44:8-12.
13. + channel. J Biol Chem 269:7839-7842.
14. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-4002.
15. Childers SR (1991) Opioid receptor-coupled second messengers. Life Sci 48:1991-2003.
16. Corbett AD, Paterson SJ and Kosterlitz HW (1993) Selectivity of ligands for opioid receptors, in Handbook of Experimental Pharmacology: Opioids I (Herz A, ed) pp 645-679, Springer-Verlag, Berlin.
17. Costa T. Klinz F-J, Vachon L and Herz A (1988.) Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Mol Pharmacol 34:744-754.
18. Costa T, Lang J, Gless C and Herz A (1990) Spontaneous association between opioid receptors and GTP-binding proteins in native membranes: Specific regulation by antagonists and sodium ions. Mol Pharmacol 37:383-394.
19. Dhawan B, Cesselin F, Raghubir R, Reisine T, Bradley P, Portoghese P and Hamon M (1996) International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 48:567-592.
20. Ehlert FJ (1985) The relationship between muscarinic receptor occupancy and adenylyl cyclase inhibition in the rabbit myocardium. Mol Pharmacol 28:410-421.
21. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH and Medzihradsky F (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the μ opioid receptor. J Pharmacol Exp Ther 278:1121-1127.
22. Emmerson PJ, Liu MR, Woods JH and Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271:1630-1637.
23. Fedynyshyn J and Lee N (1989a) Mu-type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to guanine nucleotide binding proteins. Brain Res 476:102-109.
24. 2 membranes are coupled to G-protein-mediated inhibition of adenylyl cyclase. FEBS Lett 253:23-27.
25. o in reconstituted phospholipid vesicles. J Biol Chem 264:3909-3915.
26. Furchgott RF (1966) The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 3:21-55.
27. 1A receptor. Biochemistry 33:4283-4290.
28. Gettys TW, Sheriff-Carter K, Moomaw J, Taylor IL and Raymond JR (1994b) Characterization and use of crude α-subunit preparations for quantitative immunoblotting of G-proteins. Anal Biochem 220:82-91.
29. Gierschik P, Moghtader R, Straub C, Dieterich K and Jakobs KH (1991) Signal amplification in HL-60 granulocytes: Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes. Eur J Biochem 197:725-732.
30. Gilman AG (1987) G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 56:615-649.
31. Herkenham M and Pert CB (1982) Light microscopic localization of brain opiate receptors: A general autoradiographic method which preserves tissue quality. J Neurosci 2:1129-1149.
32. Hilf G, Gierschik P and Jakobs KH (1989) Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur J Biochem 186:725-731.
33. Ivarsson M and Neil A (1989) Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance. Pharmacol Toxicol 65:368-371.
34. Kaufman D, Keith D, Anton B, Tian J, Magendzo K, Newman D, Tran T, Lee D, Wen C, Xia Y-R, Lusis A and Evans C (1995) Characterization of the murine μ opioid receptor gene. J Biol Chem 270:15877-15883.
35. Keen M (1991) Testing models of agonism for G-protein-coupled receptors. Trends Pharmacol Sci 12:371-374.
36. Kenakin T (1993) Efficacy, in Pharmacologie Analysis of Drug-Receptor Interaction (Kenakin T, ed) pp 249-277, Raven, New York.
37. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463.
38. Kenakin TP and Morgan PH (1989) Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol Pharmacol 35:214-222.
39. Laugwitz KL. Offermanns S, Spicher K and Schultz G (1993) μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron 10:233-242.
40. Law PY, McGinn TM, Wick MJ, Erikson LJ, Evans C and Loh HH (1994) Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density? J Pharmacol Exp Ther 271:1686-1694.
41. Liu-Chen L-Y, Li S, Wheeler-Aceto H and Cowan A (1991) Effects of intracerebro-ventricular β-funaltrexamine on μ and δ opioid receptors in the rat: Dichotomy between binding and antinociception. Eur J Pharmacol 203:195-202.
42. 35S]thio)triphosphate binding. Mol Pharmacol 44:115-123.
43. Lorenzen A, Guerra L, Vogt H and Schwabe U (1996) Interaction of full and partial agonists of the Al adenosine receptor with receptor/G protein complexes in rat brain membranes. Mol Pharmacol 49:915-926.
44. 2-adrenoceptor. Mol Pharmacol 48:316-325.
45. Mjanger E and Yaksh TL (1991) Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects intrathecal mu agonists. J Pharmacol Exp Ther 258:544-550.
46. o-type GTP-binding protein. J Neurosci 14:3842-3851.
47. Munson PJ and Rodbard D (1980) LIGAND: A versatile approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
48. 1A receptors as a function of receptor:G-protein stoichiometry. Neuropharmacology 36:451-459.
49. North RA, Williams JT, Surprenant A and Christie MJ (1987) μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 84:5487-5491.
50. Odagaki Y and Fuxe K (1995) 5-HT1A receptor-mediated activation of high-affinity GTPase in rat hippocampal membranes. Eur J Pharmacol 288:385-388.
51. Okuhara DY and Beck SG (1994) 5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells. J Neurophysiol 71:2161-2167.
52. Pacheco M, Ward SJ and Childers SR (1993) Identification of cannabinoid receptors in cultures of rat cerebellar granule cells. Brain Res 603:102-110.
53. Prather P, McGinn T, Erickson L, Evans C, Loh H and Law P (1994) Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density. J Biol Chem 269:21293-21302.
54. Quock R, Hosohata Y, Knapp R, Burkey T, Hosohata K, Zhang X, Rice K, Nagase H, Hruby V, Porreca F, Roeske W and Yamamura H (1997) Relative efficacies of δ-opioid receptor agonists at the cloned human δ-opioid receptor. Eur J Pharmacol 326:101-104.
55. Rhim H and Miller RJ (1994) Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J Neurosci 14:7608-7615.
56. m GTPase studies. J Pharmacol Exp Ther 263:99-104.
57. 35S]GTPγS binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 51:87-96.
58. 35S]thioltriphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
59. 35S]GTPγS autoradiography in rat brain. J Neurosci 16:2684-2692.
60. Sim LJ, Selley DE, Xiao R and Childers SR (1996b) Differences in G-protein activation by mu and delta opioid, and cannabinoid, receptors in rat striatum. Eur J Pharmacol 307:95-107.
61. Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11:319-393.
62. Thompson RC, Mansour A, Akil H and Watson SJ (1993) Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 11:903-913.
63. 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol Pharmacol 45:524-531.
64. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47:848-854.
65. 1A receptors to adenylyl cyclase. Mol Pharmacol 41:999-1007.
66. Wang J-B, Johnson PS, Persico AM, Hawkins AL, Griffin CA and Uhl GR (1994) Human μ opiate receptor: cDNA and genomic clones, pharmacological characterization and chromosomal assignment. FEES Lett 338:217-222.
67. Yu VC and Sadee W (1988) Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J Pharmacol Exp Ther 245:350-355.
68. Zernig G, Butelman ER, Lewis JW, Walker EA and Woods JH (1994) In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. J Pharmacol Exp Ther 269:57-65.
69. Zernig G, Issaevitch T, Broadbear J, Burke T, Lewis J, Brine G and Woods J (1995) Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding. Life Sci 57:2113-2125.